USFDA Flags Major cGMP Deviations at Une
New Delhi based Unexo Life Sciences has initiated a major recall of several medicated patch
Warning letters, 483s, Recalls, Import Alerts, Audit observations
New Delhi based Unexo Life Sciences has initiated a major recall of several medicated patch
Chinese OTC Manufacturer Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd was inspected by USFDA in March
USFDA inspected Granules India’s Finished Dosage and PFI facility (FEI 3004097901) at Gagillapur Village, Hyderabad
Sun Pharma’s Dadra Unit was issued FDA Warning letter in June 2024, following critical observations
USFDA had inspected the Jiangsu Hengrui Pharma’s Huanghe road site in January 2024. The site
Laurus Synthesis was issued an Untitled Letter by USFDA in May 2024, following critical observations
Everest Organics Ltd (Telangana, India) was issued a GMP Non-Compliance Report with recommendation to suspend
Sun Pharma Dadra unit was inspected by USFDA in December 2023 by FDA investigator Pratik
USFDA inspection of Cipla, Patalganga site manufacturing APIs and Tablets resulted in USFDA 483 with
Natco Pharma (india) Kothur facility was inspected by USFDA in October 2023. The site (FEI